Armata Pharmaceuticals, Inc. (ARMP) financial statements (2020 and earlier)

Company profile

Business Address 4503 GLENCOE AVENUE
MARINA DEL REY, CA 90292
State of Incorp. WA
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments685697
Cash and cash equivalents685697
Receivables   000
Other undisclosed current assets100110
Total current assets:7856107
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment211111
Intangible assets, net (including goodwill)1435102020
Goodwill3   88
Intangible assets, net (excluding goodwill)1035101212
Restricted cash and investments1     
Other noncurrent assets0     
Other undisclosed noncurrent assets 00000
Total noncurrent assets:1936122122
TOTAL ASSETS:251211183129
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:132211
Accounts payable111   
Employee-related liabilities 11100
Interest and dividends payable 000  
Other undisclosed accounts payable and accrued liabilities100111
Debt1  1  
Deferred compensation liability1     
Due to related parties    0 
Business combination, contingent consideration, liability1     
Deferred revenue and credits  00
Other liabilities   0  
Other undisclosed current liabilities   110
Total current liabilities:532422
Noncurrent Liabilities
Long-term debt and lease obligation2     
Operating lease, liability2
Liabilities, other than long-term debt411533
Deferred tax liabilities, net11233
Deferred income tax liabilities3
Business combination, contingent consideration, liability1     
Derivative instruments and hedges, liabilities 002  
Other undisclosed noncurrent liabilities    118
Total noncurrent liabilities:6115521
Total liabilities:11338723
Temporary equity, carrying amount    12 
Stockholders' equity
Stockholders' equity attributable to parent, including:158810133
Common stock000002
Additional paid in capital172414402391375363
Accumulated deficit(158)(406)(394)(381)(363)(362)
Warrants and rights outstanding     6
Other undisclosed stockholders' equity attributable to parent     (6)
Other undisclosed stockholders' equity     2
Total stockholders' equity:158810135
TOTAL LIABILITIES AND EQUITY:251211183129

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:  0000
Operating expenses(20)(13)(16)(24)(11)(15)
Other operating income, net
(Other Expenses)
     37
Other undisclosed operating loss     (37)
Operating loss:(20)(13)(16)(23)(10)(14)
Nonoperating income00241028
Debt instrument, convertible, beneficial conversion feature     28
Other nonoperating income002410 
Interest and debt expense(1)  (0)  
Other undisclosed income from continuing operations before equity method investments, income taxes1  0  
Income (loss) from continuing operations before income taxes:(19)(12)(14)(19)(1)14
Income tax benefit 0110 
Net income (loss):(19)(12)(13)(19)(1)14
Other undisclosed net income attributable to parent     9
Net income (loss) attributable to parent:(19)(12)(13)(19)(1)23
Preferred stock dividends and other adjustments   (2)(10)(1)
Other undisclosed net loss available to common stockholders, basic   (4)  
Net income (loss) available to common stockholders, basic:(19)(12)(13)(24)(11)22
Other undisclosed net loss available to common stockholders, diluted(1)(0)(2)   
Net income (loss) available to common stockholders, diluted:(20)(12)(14)(24)(11)22

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(19)(12)(13)(19)(1)14
Comprehensive income (loss), net of tax, attributable to parent:(19)(12)(13)(19)(1)14

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: